| Variables | Characteristics | Number of studies | Sample size | Prevalence (95% CI) | I2, value |
| Sample size | <200 | 3 | 344 | 57.39 (95% CI: 28.88, 85.90) | 98.33%, | >200 | 14 | 6094 | 40.69 (95% CI: 31.88, 49.49) | 98.14%, |
| Pooled prevalence of mastitis by region | Addis Ababa | 2 | 736 | 48.96 (95% CI: 44.82, 53.09) | — | Amhara | 3 | 1048 | 25.09 (95% CI: 3.86, 46.32) | 98.63%, | B/Gumuz | 1 | 384 | 39.30 (95% CI: 34.90, 43.70) | — | Oromia | 5 | 1301 | 49.90 (95% CI: 31.77, 68.03) | 98.49%, | SNNPR | 6 | 2969 | 46.66 (95% CI: 31.35, 61.96) | 98.27%, |
| Pooled prevalence of mastitis by year | 2005–2016 | 8 | 3400 | 39.97 (95% CI: 25.50, 54.44) | 98.89%, | 2017–2022 | 9 | 3038 | 46.83 (95% CI: 35.68, 57.97) | 97.57%, |
| Pooled prevalence by type of mastitis | Clinical | 17 | 6438 | 12.59 (95% CI: 7.18, 18.00) | 98.76%, | Subclinical | 17 | 6438 | 32.21 (95% CI: 24.68, 39.74) | 98.24%, | Overall | 17 | 6438 | 43.60 (95% CI: 34.71, 52.49) | 98.37%, |
|
|